1Popov VM,Zhou J,Shirley LA,et al.The cell fate determination factor DACH1 is expressed in estrogen receptoralpha-positive breast cancer and represses receptor-alpha signaling[J].Cancer Res,2009,69 (14):5752-5760.
3Sunde JS,Donninger H,Wu K,et al.Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming Growth factor-beta signaling in ovarian cancer[J].Cancer Res,2006,66 (17):8404-8412.
4Wu K,Li A,Rao M,et al.DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth[J].Mol Cell Biol,2006,26 (19):7116-7129.
5Nan F,L(u) Q,Zhou J,et al.Altered expression of DACH1 and cyclin D1 in endometrial cancer[J].Cancer Biol Ther,2009,8 (16):1534-1539.
6Yu Y,Davicioni E,Triche TJ,et al.The homeoprotein six1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis[J].Cancer Res,2006,66 (4):1982-1989.
7Li X,Perissi V,Liu F,et al.Tissue-specific regulation of retinal and pituitary precursor cell proliferation[J].Science,2002,297 (5584):1180-1183.
8Zuber ME,Perron M,Philpott A,et al.Giant eyes in Xenopus laevis by overexpression of XOptx2[J].Cell,1999,98 (3):341-352.
9Zheng W,Huang L,Wei ZB,et al.The role of Six1 in mammalian auditory system development[J].Development,2003,130 (17):3989-4000.
10Ozaki H,Nakamura K,Funahashi J,et al.Six1 controls patterning of the mouse otic vesicle[J].Development,2004,131 (3):551-562.
